UNSPSC 51143705: Benactyzine/meprobamate

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CN900. This VA Drug Class (CN900) classifies this compound as belonging to the group CNS MEDICATIONS, OTHER.

UNSPSC 51143705 Benactyzine/meprobamate is a Commodity code that, based on recent state and local activity, sees minimal solicitation under its nominal pharmaceutical scope. The single identified recent opportunity—Seminole County, Florida's IFB60459723LAS posted June 30, 2026—does not align with the code's stated product; the county solicited naloxone and safe drug deactivation systems for community health initiatives, not benactyzine/meprobamate formulations. The mismatch suggests the code either carries misclassified opportunities in state procurement systems or sees no active purchasing aligned with its intended commodity category at this time.

Seminole County's IFB called for 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, and a response deadline of July 26, 2023. Vendors were required to submit electronic bids through the county's e-Procurement Portal, include all shipping and delivery costs, and comply with E-Verify and drug-free workplace certifications. The contract offered a two-year initial term with an optional one-year renewal on a fixed-fee basis and was potentially funded through FEMA. Given the mismatch between the code's pharmaceutical name and the actual solicitation, business development professionals should verify current UNSPSC mapping in target procurement systems before pursuing this code or consider that recent activity under this commodity designation reflects miscoding rather than genuine market demand for benactyzine/meprobamate products from state and local buyers.